Wells Fargo & Company Bioventus Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BVS
# of Institutions
122Shares Held
41MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$146 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$76.8 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$60 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$26.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$18.7 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $693M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...